This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

Compact view
Research pass: stub-manual Compound SKIP-FOR-NOW HIGH

AICAR

Extended Research
High-risk compound

Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-FOR-NOW — current cost / risk / redundancy puts it below the line.

Extended Research

Our depth — beyond the mirror

Deeper analysis, verdict reasoning, and per-archetype recommendations from our research team.

Editor's verdict SKIP-FOR-NOW HIGH

Beautiful mechanism, ugly drug. (1) Oral bioavailability is near-zero → must be injected for activity. (2) Half-life ~1-2h means it requires impractical dosing schedules to mimic the rodent endurance protocol. (3) Most "AICAR" sold as research chem is unconfirmed peptide-supplier material with no third-party COA — same supply chain as the worst of the AAS gray market. (4) WADA-banned, so anyone competition-tested is out. (5) The endurance benefit in the Narkar study was at doses that scale to grams per day in humans, well above any practical "biohacking" use. Reasonable alternatives that target the same AMPK pathway with vastly better risk profile: metformin, berberine, exercise, fasting. Verdict flips to WATCH-LIST only if (a) a real oral prodrug becomes available (the GP531 / acadesine pulmonary-hypertension trials hinted at one), or (b) Dylan moves to a non-tested ultra-endurance context with documented sourcing. Stays SKIP-FOR-NOW now.

Research pass: stub-manual
Sourcing deep dive

Gray-market peptide vendors only. No legitimate supply chain. Quality and identity unverifiable without LC-MS testing.

Verdict change log
  • 2026-06-05 — Initial verdict SKIP-FOR-NOW. Mechanism interesting, drug unusable, alternatives better. (stub)
Open questions / gaps Open
  • Whether GP531 / next-gen acadesine prodrugs will revive an oral form.
  • Whether intermittent (acute high-dose) AICAR matters more or less than chronic (low-dose) for endurance adaptation.

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…